Hillsdale Investment Management »

Biosante Pharmaceuticals shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 69k 55.14
2023-09-30 $4.0M 70k 58.06
2023-06-30 $4.3k 80 53.83

More positions owned by Hillsdale Investment Management

Celestica (CLS)
Docebo (DCBO)
Shopify Inc cl a (SHOP)
Lightspeed Comme (LSPD)
Rbc Cad (RY)
Manulife Finl Corp (MFC)
New Gold Inc Cda (NGD)
Ego (EGO)
Sun Life Financial (SLF)
Stantec (STN)
Primo Water (PRMW)
Kinross Gold Corp (KGC)
Cibc Cad (CM)
Cgi Inc Cl A Sub Vtg (GIB)
North American Const (NOA)

View all positions for Hillsdale Investment Management

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Assenagon Asset Management
Principal Financial Group
WEDGE Capital Management L

View all funds holding Biosante Pharmaceuticals